LAURA MIZELL: Open Payments
NPI 1457892648 · MONTGOMERY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 122 payments from 22 companies in 2025. Trend: 2023 $1,857 · 2024 $1,943 · 2025 $2,179
Food & beverage: $2,179
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $403 |
| GlaxoSmithKline, LLC. | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 11 | $227 |
| Amgen Inc. | 10 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $146 |
| Lilly USA, LLC | 11 | $142 |
| Sumitomo Pharma America, Inc. | 8 | $131 |
| PFIZER INC. | 5 | $119 |
| Exact Sciences Corporation | 6 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $91 |
Products named: Wegovy, Ozempic, Kerendia, SHINGRIX, GEMTESA, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
